Table I.
PTPRG-AS1, ZXF2, BLACAT2, FOXP4-AS1 and UCC expression levels and their associations with clinical characteristics of patients.
| PTPRG-AS1 | ZXF2 | BLACAT2 | FOXP4-AS1 | UCC | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Characteristics | n (%) | High | Low | P-value | High | Low | P-value | High | Low | P-value | High | Low | P-value | High | Low | P-value |
| Sex | 61 | 27 | 34 | 0.743 | 35 | 26 | 0.241 | 33 | 28 | 0.039 | 30 | 31 | 0.043 | 21 | 40 | 0.044 |
| Male | 42 (68.9) | 18 | 24 | 22 | 20 | 19 | 23 | 17 | 25 | 11 | 31 | |||||
| Female | 19 (31.1) | 9 | 10 | 13 | 6 | 14 | 5 | 13 | 6 | 10 | 9 | |||||
| Age (years) | ||||||||||||||||
| <60 | 25 (41.0) | 11 | 14 | 0.973 | 16 | 9 | 0.383 | 15 | 10 | 0.441 | 12 | 13 | 0.878 | 6 | 19 | 0.153 |
| ≥60 | 36 (59.0) | 16 | 20 | 19 | 7 | 18 | 18 | 18 | 18 | 15 | 21 | |||||
| LNM | ||||||||||||||||
| Present | 46 (75.4) | 20 | 26 | 0.829 | 29 | 17 | 0.117 | 24 | 22 | 0.597 | 25 | 21 | 0.157 | 19 | 27 | 0.048 |
| Absent | 15 (24.6) | 7 | 8 | 6 | 9 | 9 | 6 | 5 | 10 | 2 | 13 | |||||
| Tumor grade | ||||||||||||||||
| 1/2 | 10 (16.4) | 6 | 4 | 0.273 | 7 | 3 | 0.494 | 7 | 3 | 0.319 | 7 | 3 | 0.182 | 5 | 5 | 0.291 |
| 3 | 51 (83.6) | 21 | 30 | 28 | 23 | 26 | 25 | 23 | 28 | 16 | 35 | |||||
| Tumor size | ||||||||||||||||
| <6 cm | 36 (59.0) | 16 | 20 | 0.973 | 17 | 19 | 0.054 | 19 | 17 | 0.804 | 19 | 17 | 0.500 | 12 | 24 | 0.829 |
| ≥6 cm | 25 (41.0) | 11 | 14 | 18 | 7 | 14 | 11 | 11 | 14 | 9 | 16 | |||||
| Ki67 status | ||||||||||||||||
| Positive | 41 (67.2) | 14 | 27 | 0.023 | 19 | 22 | 0.013 | 21 | 20 | 0.518 | 20 | 21 | 0.929 | 11 | 30 | 0.074 |
| Negative | 20 (32.8) | 13 | 7 | 16 | 4 | 12 | 8 | 10 | 10 | 10 | 10 | |||||
| Ki67 expression (%) | ||||||||||||||||
| <50 | 37 (60.7) | 18 | 19 | 0.392 | 23 | 14 | 0.348 | 20 | 17 | 0.993 | 18 | 19 | 0.918 | 12 | 25 | 0.684 |
| ≥50 | 24 (39.3) | 9 | 15 | 12 | 12 | 13 | 11 | 12 | 12 | 9 | 15 | |||||
LMN, lymph node metastasis; PTPRG-AS1, PTPRG antisense RNA 1; FOXP4-AS1, forkhead box P4 antisense RNA 1; BLACAT2, bladder cancer-associated transcript 2; UCC, upregulated in colorectal cancer.